Are GLP-1 drugs relevant in peri or post menopause?

Yes as metabolic tools when prescribed for approved indications such as type 2 diabetes or chronic weight management where labeled. Menopause-related body-composition change is a real clinical conversation. These are FDA-approved drugs with known risk profiles, which puts them in a different category than unapproved research peptides. Timing in peri or post, muscle preservation, and protein intake matter. None of that replaces medical supervision of the prescription.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of peri and post menopause. What changes after peri, how people discuss peptides next to HRT or TRT, and where the evidence actually stops.